
Heidelberg Engineering will host its first International Glaucoma Symposium in conjunction with Mainz University on 1 February, 2025, bringing together specialists from around the world.
The event calls for artificial intelligence (AI) to be fully implemented, noting that an increasing number of glaucoma and diabetic patients are diagnosed, often when the condition is advanced. With a limited number of clinicians in many countries, AI can be used to aid disease detection, and speed patient processing.
The symposium will be held onsite at the University Eye Clinic at Mainz, which is easily reached from Frankfurt airport. It is open to all ophthalmologists and those involved in the application of AI to this specialty.
Encouraging the profession to attend, Heidelberg Engineering Clinical Director Glaucoma, Dr Stephan Schulz said, “We will be hearing from world specialists about their experiences and aspirations for the development of AI models for patient identification and disease progression predictions. The open forum session during the afternoon is designed to encourage an inspiring and educational exchange of ideas and experiences.”
The event calls for artificial intelligence (AI) to be fully implemented, noting that an increasing number of glaucoma and diabetic patients are diagnosed, often when the condition is advanced
Find out more and register to attend at the International Glaucoma Symposium (IGS).